Showing results (1431-1440 of 1,708) with videos related to
Sort By:
Pageof 171
European Journal of Preventive Cardiology|September 19, 2025
Association between lipoprotein(a) and cardiovascular events in patients with peripheral artery disease: the Mass General Brigham Lp(a) registryDaniel J McClintick, David W Biery, Adam N Berman, et al.The New England Journal of Medicine|September 3, 2013
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitusBenjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, et al.European Heart Journal|November 30, 2017
External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registryArthur Darmon, Deepak L Bhatt, Yedid Elbez, et al.International Journal of Cardiology|June 26, 2018
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trialsChristoph B Olivier, Vandana Sundaram, Deepak L Bhatt, et al.Journal of the American College of Cardiology|April 24, 2024
Limb Outcomes With Ticagrelor Plus Aspirin in Patients With Diabetes Mellitus and AtherosclerosisMarc P Bonaca, Deepak L Bhatt, Tabassome Simon, et al.JAMA Neurology|February 9, 2024
Time to Anticoagulation Reversal and Outcomes After Intracerebral HemorrhageKevin N Sheth, Nicole Solomon, Brooke Alhanti, et al.Journal of the American College of Cardiology|April 28, 2022
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial InfarctionPrakriti Gaba, Deepak L Bhatt, Ph Gabriel Steg, et al.Resuscitation|February 22, 2019
Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trialMichal Droppa, Muthiah Vaduganathan, Ramkumar V Venkateswaran, et al.American Heart Journal|December 1, 2012
Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter studyFausto Feres, Ricardo A Costa, Deepak L Bhatt, et al.Cardiovascular Diagnosis and Therapy|November 19, 2019
A low-cost machine learning-based cardiovascular/stroke risk assessment system: integration of conventional factors with image phenotypesAnkush Jamthikar, Deep Gupta, Narendra N Khanna, et al.Pageof 171